WINFertilitys' approach is to promote high quality infertility care at the most competitive cost.
WHITE PLAINS, NY (PRWEB) January 18, 2012
WINFertility, Inc., the leader in Infertility Management Programs for insurers and employers, today announced the extension of its consumer offering to the greater Atlanta region, its fifth major marketplace in as many months. The expansion is designed to increase the availability of affordable, advanced fertility care that remains financially out of reach for many of the nearly quarter million Georgians facing infertility today who are without advanced infertility insurance coverage.
WINFertility has developed evidence-based treatment protocols for IUI, IVF and Third Party Reproduction, delivered by a contracted, credentialed network of fertility specialists. Infertility medications are included in the single, discounted, bundled price for Program participants. There is no age or medical criteria required to enroll in the Program. If treatment is indicated by a participating provider and the patient has no infertility insurance coverage, or has exhausted their benefit, she can enroll in the WINFertility Program. Typical patient savings per IVF treatment cycle can range from $5,000 to $10,000 or more, depending on treatments and medication doses required.
Incorporated in the unique Consumer Program is access to WINFertility’s FertilityCoach Nurses(SM) on a 24/7 basis for education and care coordination, a Medical Advisory Board comprised of industry-leading Reproductive Endocrinologists and financing programs at preferred rates.
Program Available Throughout Metropolitan Atlanta
Effective today, the WINFertility Quality Discount Treatment Program is available in the greater Atlanta area through Georgia Reproductive Specialists (GRS). Infertility patients in the region are treated at four conveniently located offices in Atlanta, Alpharetta, Decatur and Stockbridge. The experienced team of specialists at GRS provides a full range of infertility services, from female and male testing and diagnosis, through IUI, IVF, Donor Programs and pre-implantation genetic diagnosis (PGD). “The GRS team has long believed that the challenging economic environment should not limit access for couples seeking solutions to their fertility problems”, said Mark Perloe, MD and Medical Director of Georgia Reproductive Specialists. “We initiated a breakthrough program in Georgia called No Hidden Fee IVF that includes all medical and laboratory procedures that are part of a typical IVF treatment cycle. We were not able to include medications and pharmacy distribution.” According to Perloe, “By partnering with WINFertility, GRS patients have unique access to a discounted, bundled package that includes both IVF treatment and medications at a much more affordable price, so more people will be able to pursue their family-building dreams. The addition of the WINFertility Treatment Program reinforces the Georgia Reproductive Specialists’ philosophy of providing affordable treatment. We expect it to be a terrific partnership and deliver added value to our patients.”
More Access for More Patients
“Georgia is home to almost 10 million people, with nearly half residing in the greater Atlanta area. We are so pleased to be able to offer our unique program to such a large and dynamic marketplace, where so many suffer with the diagnosis of infertility and its associated expenses,” commented Tom Boyajy, COO of WINFertility. “The WINFertility approach is to promote high quality infertility care at the most competitive cost. The GRS team is recognized for both their patient-centered approach and their clinical results. Coupled with WIN’s proprietary treatment protocols, bundled packages, fertility management expertise, and considerable buying power, we are confident that patients in Georgia will receive the very best treatment value possible.”
“The response WIN has received about our Consumer Program continues to be very positive”, said Boyajy. “This encouraging reception is due to the compelling financial and clinical benefits of WIN’s offering that are unique in each marketplace we have entered. To continue to meet market demand and provide greater program access to patients who require fertility help, we have accelerated our expansion timetable and expect to announce several more new markets over the coming months.”
Founded in 2000, WINFertility is the national leader in Infertility Management Programs, annually managing infertility treatment for many thousands of infertility patients for major insurers and employers. WIN is leveraging their decade-long experience and clinical results in the fertility field, direct contracts with fellowship-trained fertility specialists, pharmaceutical manufacturers and national specialty pharmacies, to offer this unique direct-to-consumer program. Now, self-paying patients in Georgia, Florida, Illinois, Minnesota and New York can enroll in the WINFertility Program and take advantage of WIN’s integrated platform to access evidence-based protocols, quality providers and discounts enjoyed by the largest healthcare purchasers.